Using QbD and Risk Tools to Strengthen Design Qualification Justifications Using QbD and Risk Tools to Strengthen Design Qualification Justifications The pharmaceutical industry continues to advance its methodologies to enhance compliance with global regulatory standards. Consequently, the integration of Quality by Design (QbD) and risk assessment tools in the design qualification (DQ) process has become paramount. This article elaborates on the relevance of QbD principles, the significance of risk-based design qualification methodologies, and their application in demonstrating compliance with Good Manufacturing Practices (GMP) as per regulatory expectations in the US, UK, and EU. Understanding Design Qualification (DQ) in GMP Framework…

How to review P and IDs, layouts and datasheets as part of DQ How to review P and IDs, layouts and datasheets as part of DQ In the dynamic field of pharmaceutical manufacturing, the design qualification (DQ) of new equipment is a critical step that ensures compliance with regulatory expectations and establishes a solid foundation for quality management systems. Proper alignment with guidelines issued by the FDA, EMA, and MHRA is essential for maintaining compliance throughout the lifecycle of pharmaceutical products. This article serves as a comprehensive guide targeting pharmaceutical professionals on how to efficiently review P&IDs, layouts, and datasheets…

Internal audit focus areas for design qualification and early project phases Internal Audit Focus Areas for Design Qualification and Early Project Phases Design Qualification (DQ) is a crucial element in the lifecycle of any new GMP (Good Manufacturing Practice) equipment and systems. As organizations in the pharmaceutical and biotechnology sectors strive to meet regulatory requirements established by the FDA, EMA, and MHRA, the emphasis on rigorous auditing and qualification processes becomes imperative. This article outlines key focus areas related to DQ and explores best practices during early project phases, providing a comprehensive look at the components critical to achieving compliance….

Risk Based Approaches to Focusing DQ Effort on High Impact Systems Risk Based Approaches to Focusing DQ Effort on High Impact Systems In the context of pharmaceutical manufacturing and product development, Design Qualification (DQ) plays a critical role in ensuring that new equipment and systems are fit for their intended purpose. As regulatory bodies like the US FDA, the EMA, and the MHRA strengthen their guidance on equipment qualification and calibration, adopting a risk-based approach to DQ becomes essential. This article offers a comprehensive exploration of how to align DQ efforts with the principles of risk management, ultimately enhancing compliance…

Design Qualification for Digital Systems, SCADA, PLC and Data Integrity Aspects Design Qualification for Digital Systems, SCADA, PLC and Data Integrity Aspects The design qualification (DQ) process plays a crucial role in ensuring that new equipment and systems within the pharmaceutical industry comply with the stringent requirements set forth by regulatory bodies like the FDA, EMA, and MHRA. This comprehensive guide examines the intricacies of design qualification, with a focus on digital systems, SCADA, PLC, and the vital aspect of data integrity. Understanding Design Qualification (DQ) Design qualification is a subset of equipment qualification, which ensures that the design of…

How to tie design qualification decisions into CQV and lifecycle planning How to Tie Design Qualification Decisions into CQV and Lifecycle Planning The integration of design qualification (DQ) into the Continued Qualification Verification (CQV) framework and overall lifecycle planning is a critical component for the pharmaceutical industry to ensure compliance with Good Manufacturing Practice (GMP) standards. This process not only validates the performance of new equipment but also aligns it with the overarching goals of Quality by Design (QbD) principles. This comprehensive article will illuminate the processes involved, establishing a thorough understanding of how DQ decisions intertwine with efficient CQV…

Governance and Approval Workflows for DQ Packages in Regulated Companies Governance and Approval Workflows for DQ Packages in Regulated Companies The design qualification (DQ) process is essential in guaranteeing that new equipment entering pharmaceutical and biopharmaceutical manufacturing complies with Good Manufacturing Practices (GMP) and regulatory expectations. Faulty equipment can hinder productivity, increase operational costs, and expose the firms to regulatory scrutiny and compliance failures. This article elaborates on the governance and approval workflows for DQ packages in regulated companies while paying special attention to the design qualification process, risk-based approaches, templates, and relevant regulations applicable in the US, UK, and…

Design Qualification for Utilities, HVAC and Support Systems under GMP Design Qualification for Utilities, HVAC and Support Systems under GMP The design qualification (DQ) is a critical phase in the lifecycle of a new piece of equipment or system utilized in the pharmaceutical industry. This includes utilities and HVAC systems that support Good Manufacturing Practices (GMP). The objective of this article is to provide an exhaustive overview of design qualification in accordance with FDA guidelines, as well as perspectives from EMA and MHRA, specifically aimed at pharma professionals, clinical operations, regulatory affairs, and medical affairs experts based in the US,…

Future of DQ Digital Twins, Model Based Design and Integrated Risk Analytics Future of DQ Digital Twins, Model Based Design and Integrated Risk Analytics The pharmaceutical industry is undergoing significant transformations, with advancements in technology leading to improved practices in Design Qualification (DQ) and equipment validation processes. This regulatory explainer manual offers comprehensive guidance on the future of DQ, focusing on digital twins, model-based design, and integrated risk analytics. Intended for pharmaceutical professionals, clinical operations, and regulatory affairs specialists, this article aligns with FDA, EMA, and MHRA regulatory standards and explores critical methodologies that can enhance equipment qualification and calibration…

Training Engineers and QA on Practical DQ Execution in Real Projects Training Engineers and QA on Practical DQ Execution in Real Projects Design Qualification (DQ) is a critical component in the lifecycle of any new GMP equipment in the pharmaceutical industry. The execution of a robust DQ process is paramount to ensure not only compliance with regulatory requirements established by the FDA, EMA, and MHRA but also to contribute to the overall quality of pharmaceutical products. This article serves as a comprehensive guide for pharma professionals, clinical operations teams, regulatory affairs, and medical affairs personnel, focusing on best practices in…